On March 11, 2020, the World Health Organization declared COVID-19 a pandemic. In the 2 years since then, millions of lives have been lost or forever changed.
Our COVID-19 Research Registry includes top-ranked, COVID-19 research articles, curated by experts, and serves as a resource for scientists working together to accelerate SARS-CoV-2 research.
We are committed to broadly disseminating research relevant to public health emergencies. This collection highlights all COVID-19/SARS-CoV-2 research published across ASM Journals.
ASM has played a key role in educating Congress, informing legislation and building support for pandemic-related policies rooted in science.
Providing Trusted Information
Timeline of Events
Shaping the U.S. Response
July 2020: ASM Defends Science-Based Health Policy in Letter to Executive Branch
Feb. 9, 2021: ASM Endorses RISE Act of 2021 to Support Research
Dec. 23, 2021: ASM Submits Comments on Cures 2.0 Legislation
Jan 21, 2022: ASM Discourages Congress's Research-Stifling COVID Investigation
Feb 4, 2022: ASM Comments on Draft PREVENT Pandemics Act
Leading on Diagnostics and Testing
Podcast Testing for COVID-19 During the Age of Omicron
The Omicron variant of SARS-CoV-2 has become the dominant variant of the virus, causing an unprecedented rise in the number of cases of COVID-19 in the U.S. and elsewhere. This has quickly led to some surprising claims about diagnostic testing for Omicron and a renewed appreciation of the importance of sequencing the viral genome for typing purposes.
Note that ASM retains copyright for these infographics. They may be used for personal or non-commercial, educational purposes only with the following citation: "American Society for Microbiology, 2022." Please contact firstname.lastname@example.org for other uses.
Hear From Experts
Progress on Omicron-Specific VaccinesUpdated February 11, 2022
ASM President-Elect Colleen Kraft, M.D., the Associate Chief Medical Officer at Emory University Hospital and associate professor in the Department of Medicine, discusses the ongoing COVID-19 pandemic in a CNN interview aired January 2022.
Watch past COVID-19 Research Registry virtual journal club recordings where SARS-CoV-2 research is presented and discussed in depth by a panel of experts. Topics include long COVID, emerging variants, vaccines and therapeutics.
View COVID-19 Registry Virtual Journal Clubs
Watch Past Registry Virtual Journal Club Sessions
A study in which 36 volunteers were infected with SARS-CoV-2, and what was learned about the kinetics of virus reproduction in the nose and throat, development of symptoms, and reliability of lateral flow antigen assays.
Determining the number of neutralizing epitopes on the SARS-CoV-2 spike that are recognized by antibodies.
COVID-19 mRNA vaccination of both uninfected and previously infected persons elicits cross-variant neutralizing antibodies, and directed evolution of a bacterial protein to form a virus-like capsid that specifically packages its encoding mRNA.
Pandemic Preparedness and Forward Thinking
Press Release Planning for a Post-COVID-19 Research Ecosystem
ASM CEO Stefano Bertuzzi and ASM President Victor DiRita penned an editorial, published in mBio, calling for the scientific community to begin planning for major changes that will significantly alter the foundation of the post-COVID-19 scientific research system.